Trinity Biotech Welcomes New Director for Biosensor Marketing
![Trinity Biotech Welcomes New Director for Biosensor Marketing](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Trinity Biotech Welcomes New Biosensor Marketing Director
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the appointment of David Ouston as Biosensor Marketing Director. Mr. Ouston brings a wealth of commercial experience driving the growth of glucose monitoring devices at large, established companies across global markets.
Remarks from Leadership
John Gillard, President and Chief Executive Officer of Trinity Biotech, expressed, “We remain focused on our innovative, needle-free, reusable continuous glucose monitoring (CGM) technology as a key long-term growth driver for Trinity Biotech, and we are delighted to welcome David as a strategic appointment to our expanding team to help further this mission. His extensive global leadership experience in promotion and market access strategies for diabetes management devices and digital solutions will be a strong asset for Trinity Biotech as we prepare the roll out of our own CGM in rapidly growing diabetes and wellness markets.”
David Ouston’s Vision
Commenting on his appointment, Mr. Ouston said, “I am thrilled to join Trinity Biotech to help realize its vision for an accessible and innovative CGM in global markets. Trinity’s device offers promising and exciting innovation in wearable biosensor technology and wellness analytics that can benefit more people globally to improve public health. I’m excited to work with this impressive team in delivering a truly disruptive and valuable solution to markets globally.”
David Ouston’s Experience
Mr. Ouston’s career spans 16 years in the glucose monitoring and diabetes health sectors, including global and EMEA regional marketing roles at Johnson & Johnson and LifeScan, where he led innovations in the OneTouch glucose monitoring portfolio. Previously, he held marketing positions at a private healthcare provider, where he supported the promotion of their global healthcare brand. Mr. Ouston holds a Bachelor of Arts Degree in Business Administration from Brunel University in the U.K.
About Trinity Biotech
Trinity Biotech is a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures, and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable biosensor industry. Trinity Biotech intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Our products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma, and whole blood. Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners.
Contact Information
For inquiries, please contact:
Trinity Biotech plc
Gary Keating
Phone: (353)-1-2769800
LifeSci Partners, LLC
Eric Ribner
Phone: (1)-646-751-4363
Email: investorrelations@trinitybiotech.com
RedChip Companies Inc.
Dave Gentry, CEO
Phone: (1)-407-644-4256
Email: TRIB@redchip.com
Frequently Asked Questions
What is the primary focus of Trinity Biotech?
Trinity Biotech focuses on human diagnostics and diabetes management solutions, including wearable biosensors.
Who has been appointed as the new Marketing Director?
David Ouston has been appointed as the Biosensor Marketing Director.
What is the significance of the new appointment?
David Ouston brings a wealth of experience in driving the growth of glucose monitoring devices and will help further the rollout of new products.
What are Trinity Biotech's future plans?
Trinity Biotech plans to develop a range of biosensor devices and services, starting with a continuous glucose monitoring product.
How can I contact Trinity Biotech for more information?
You can contact Trinity Biotech plc or LifeSci Partners via the provided contact details above.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- ProVen VCT plc Plans Exciting New Fundraise
- Bright Green Partners with Benuvia for Raw Material Supply
- Growth Insights for Global Pharma Grade Plastic Packaging Market
- High-Performance Computing Market Growth to USD 92.33 Billion
- Cancer Vaccines Market Growth Forecast and Insights
- Performance Coatings Market Growth Opportunities
- Industrial Robotics Market Growth Projections for 2032
- Significant Growth Ahead for Blood Culture Tests Market
- Biotechnology Sector Expected to Surge by 2034
- CytoDyn Partners with CRO for Phase II Inflammation Study